Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OBEVIDOS: Vitamin D Supplementation in Obese Children
NCT03516968Phase 3Recruiting
- Sponsor
- Hospices Civils de Lyon
- Start
- Dec 2023
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vitamin d in Vitamin D deficiency (VDD) (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Proportion of patients reaching the therapeutic target defined as vitamin D (25(OH)D) serum level ≥ 50 nmol/L and < 120 nmol/L at Month 3. Started Dec 2023; status: recruiting.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT03516968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03516968.